Compugen director files initial Form 3 holdings
Compugen Ltd director Anat Cohen-Dayag has filed an initial ownership report showing existing equity holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Compugen Ltd director Anat Cohen-Dayag has filed an initial ownership report showing existing equity holdings in the company. She holds 108,622 Ordinary Shares directly, including 36,091 restricted stock units (RSUs) that vest in 11 equal quarterly installments beginning on March 31, 2026, subject to continued service.
She also holds multiple share options to buy Ordinary Shares, with exercise prices ranging from $1.02 to $14.40 and expiration dates between 2026 and 2035. This filing records current positions and does not report any new purchases or sales of Compugen shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (6)
- F1. Includes 36,091 restricted stock units ("RSUs"). The RSUs vest in 11 equal quarterly installments commencing on March 31, 2026, subject to the Reporting Person's continued service to the Issuer.
- F2. Fully vested.
- F3. This option vested 25% on March 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- F4. This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- F5. This option vested 25% on September 30, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- F6. This option vests 25% on September 30, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Anat Cohen-Dayag’s Form 3 filing for COMPUGEN LTD (CGEN) show?
How many RSUs are included in Anat Cohen-Dayag’s Compugen holdings, and how do they vest?
What stock options does Anat Cohen-Dayag report in Compugen’s Form 3 filing?
What vesting terms are disclosed for Anat Cohen-Dayag’s Compugen stock options?
AI-generated analysis. How Rhea-AI works. Not financial advice.
